[{"id":"f7ec00b1-9612-4461-b58e-a7754245e0c1","acronym":"","url":"https://clinicaltrials.gov/study/NCT03196830","created_at":"2021-01-18T15:45:46.880Z","updated_at":"2024-07-02T16:37:00.593Z","phase":"Phase 2","brief_title":"CAR-T for R/R B-NHL","source_id_and_acronym":"NCT03196830","lead_sponsor":"The First Affiliated Hospital of Soochow University","biomarkers":" CD20 • TNFRSF8 • CD22","pipe":"","alterations":" ","tags":["CD20 • TNFRSF8 • CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CAR-T CD19/CD20/CD22/CD30"],"overall_status":"Unknown status","enrollment":" Enrollment 10","initiation":"Initiation: 06/01/2017","start_date":" 06/01/2017","primary_txt":" Primary completion: 05/31/2021","primary_completion_date":" 05/31/2021","study_txt":" Completion: 05/31/2021","study_completion_date":" 05/31/2021","last_update_posted":"2019-04-16"}]